July 7, 2020
June 2020: Supporting review on management of chemotherapy-induced HFS
Although Hand-Foot Syndrome (HFS) is not life threatening, it can cause a significant discomfort and impairment of function. Especially…
Read More
July 6, 2020
March 2020: Meducom celebrates its 15th anniversary!
Following 10 years of academic medical research combined with many years of experience in the…
Read More
June 18, 2020
November 2019: Meducom wins competitive pitch
At the end of 2019, Meducom was invited by an international biotechnology company specialised in…
Read More
June 18, 2020
September 2019: Meducom supports regulatory affairs with safety reports
Periodic Safety Update Reports (PSURs) and Periodic Benefit-Risk Evaluation Reports (PBRERs) are typical pharmacovigilance documents.…
Read More
November 15, 2019
July 2019: Meducom supports development guidance and recommendations to address complications of rare disease
Gaucher disease (GD) is a rare, genetic lysosomal disorder leading to lipid accumulation and dysfunction…
Read More
November 12, 2019
March 2019: Meducom supports manuscript development
March 2019: Meducom supports manuscript development on real-life experiences in the treatment of gastric cancer…
Read More
June 21, 2018
June 2018 Meducom launches her totally renewed website
With pride we present our totally renewed website with a fresh and contemporary look. Our…
Read More
May 18, 2018
April 2018: Development “toolbox” use MRI with MS patients
Over the past months, Meducom developed for one of her clients an educational modular program…
Read More
January 9, 2018
December 2017: Meducom supports advisory board
Shortly before the holidays, Meducom developed and organised a nephrology advisory board in Belgium for…
Read More
December 23, 2017
November 2017: V&VN Symposium
In July 2017, Meducom supported a pharmaceutical company in the Netherlands by creating the programme…
Read More